Biologically augmented core decompression for the treatment of osteonecrosis of the femoral head

Techniques in Orthopaedics

Volumn 16, Issue 1, 2001, Pages 32-38

  Ciombor, Deborah McK ^a,b   Aaron, Roy K ^a  

^a BROWN UNIVERSITY   (United States)

^b RHODE ISLAND HOSPITAL   (United States)

Author keywords

Bone graft; Bone morphogenic proteins; Core decompression; Demineralized bone matrix; Electric and electromagnetic stimulation

Indexed keywords

BONE MORPHOGENETIC PROTEIN;

ARTICLE; BONE DEMINERALIZATION; BONE GRAFT; DECOMPRESSION SURGERY; FEMUR HEAD NECROSIS; HUMAN; MAGNETIC STIMULATION; OSSIFICATION; OSTEOLYSIS; SURGICAL TECHNIQUE;

EID: 0034931830     PISSN: 08859698     EISSN: None     Source Type: Journal    
DOI: 10.1097/00013611-200103000-00005     Document Type: Article

References (34)

1. Acceleration of experimental endochondral ossification by biophysical stimulation of the progenitor cell pool
2. Electrical stimulation, demineralized bone matrix, and bone morphogenic protein
3. Electrical stimulation of bone induction and grafting
4. Core decompression augmented with human decalcified bone matrix graft for osteonecrosis of the femoral head
5. Electrical stimulation of human femoral intertrochanteric osteotomies
6. Gene expression during endochondral bone development: Evidence for coordinate expression of transforming growth factor and collagen type I
7. Survivorship analysis of hips treated with core decompression for non-traumatic osteonecrosis of the femoral head
8. Structural consequences of subchondral bone involvement in segmental osteonecrosis of the femoral head
9. Identification of transforming growth factor B family members present in bone-inductive protein purified from bovine bone
10. Influence of electromagnetic fields on endochondral bone formation
11. The controversy of core decompression of the femoral head for osteonecrosis
12. Biologic principles of bone induction: Application to bone grafts
13. Ovine osteonecrosis of the femoral head - The role of bone morphogenic protein
14. Idiopathic bone necrosis of the femoral head: Early diagnosis and treatment
15. IGF-II receptor number is increased in TE-85 cells by low-amplitude, low frequency electromagnetic field (EMF) exposure
16. The biology of osteonecrosis of the human femoral head and its clinical implications: I. Tissue biology
17. The biology of osteonecrosis of the human femoral head and its clinical implications: II. The pathological changes in the femoral head as an organ and in the hip joint
18. Response: The role of core decompression in the treatment of ischemic necrosis of the femoral head
19. Effects of electromagnetic stimuli on bone and bone cells in vitro inhibition of responses to parathyroid hormone by low-energy, low-frequency fields
20. Non-traumatic avascular necrosis of the femoral head
21. Pulsating electromagnetic field stimulates mRNA expression of bone morphogenetic protein -2 and -4
22. Expression of insulin-like growth factors during bone induction in the rat
23. Formation of osteoclast-like cells is suppressed by low frequency, low intensity electric fields
24. Prevention of osteoporosis by pulsed electromagnetic fields
25. The role of insulin-like growth factor II in magnetic field regulation of bone formation
26. Pulsed electromagnetic fields induce osteogenesis and upregulate bone morphogenetic protein-2 and 4 mRNA in rat osteoblasts in vitro
27. Augmentation of subchondral bone formation in AVN with rhBMP-2
28. A double blind trial of pulsed electromagnetic fields for delayed union of tibial fractures
29. Modulation of bone loss during disuse by pulsed electromagnetic fields
30. Core decompression of the osteonecrotic femoral head
31. Capacitive coupling as an adjunctive treatment for avascular necrosis
32. Osteonecrosis of the femoral head: Results of core decompression and grafting with and without electrical stimulation
33. Treatment of osteonecrosis of the femoral head by core decompression, bone grafting and electrical stimulation
34. Effects of pulsing electromagnetic fields on gene expression of bone morphogenetic proteins in human osteoblastic cell line in vitro